Viewing Study NCT02015494


Ignite Creation Date: 2025-12-25 @ 1:47 AM
Ignite Modification Date: 2026-04-16 @ 5:39 AM
Study NCT ID: NCT02015494
Status: UNKNOWN
Last Update Posted: 2015-03-06
First Post: 2013-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
Sponsor: VaxInnate Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module